Bronchopulmonary Dysplasia Drug Market Research on Surfactants and Corticosteroid Treatments
The Bronchopulmonary Dysplasia Drug Market is experiencing sustained expansion as neonatal intensive care capabilities continue to improve across both developed and emerging economies. Bronchopulmonary dysplasia (BPD) is a chronic respiratory condition that primarily affects premature infants who require prolonged oxygen support or mechanical ventilation after birth. With advances in perinatal...
0 Comments 0 Shares 65 Views 0 Reviews